Individuals with other substance use disorders, severe mental disorders, use of AUD medications, or a history of pancreatitis, diabetes, or alcohol withdrawal seizures were excluded
ClinicalTrials.gov for trial status (search retatrutide), Eli Lilly's investor relations page for readout announcements, and the FDA's Drugs@FDA database for the eventual approval
Although both medications belong to the GLP-1 category, they are not identical
Allergic Reactions : Rash, itching, swelling, severe dizziness, or difficulty breathing require urgent medical care
Understanding GLP-1 Medications: What the Research Shows To evaluate whether GLP-1 medication might be worth considering, it helps to understand what these medications do based on published research, not marketing claims